Why is DVT More Common In the Left Leg? Dr Raheel Moazzam’s New Study Gives Answers!
Dr Raheel Moazzam, Ultrasound specialist at ROC Clinic, posted on LinkedIn:
“Why is DVT more common in the left leg? It might be more than just “compression.”
I am excited to share the findings of my recent research at Imperial College London, where I investigated the anatomical markers that predispose individuals to Deep Vein Thrombosis (DVT).
While left-sided DVT is traditionally linked to May–Thurner syndrome (external compression by artery), my study explores a different angle: Intrinsic anatomy.
Key Takeaways from the Study:
- The “Left-Side” Difference: Even in asymptomatic individuals without external compression, the left common iliac vein (LCIV) was significantly narrower—averaging 2mm smaller than the right.
- An Independent Risk Factor: This narrowing appears to be a stable, intrinsic anatomical trait. It did not correlate with common risk factors like BMI or hydration status, suggesting some of us may simply be “wired” with a higher baseline risk for venous stasis.
- Proactive vs. Reactive: This research highlights a potential shift in how we screen for DVT. By identifying these anatomical variations early via duplex ultrasound, we could move toward proactive prevention for high-risk individuals.
Vascular health is often about the things we cannot see. I hope this work contributes to better risk stratification and earlier interventions for those at risk of iliofemoral DVT.
A huge thank you to my mentor, Dr. Mohammed Farid Aslam, and the team at the Heart and Lungs Institute for their invaluable support.
I’ve attached the full article below. I’d love to hear your thoughts, especially from fellow vascular scientists and clinicians!”
Title: Iliac Vein morphology and deep vein thrombosis: a cross-sectional analysis
Authors: Dr Raheel Moazzam, Dr. Mohammed Farid Aslam
Read full study here.
More posts exploring DVT and other hematology diseases in Hemostasis Today.
-
Apr 19, 2026, 15:59Nour Al-Mozain: Why Stem Cell Collection Parameters Need Adjustment in SCD for Gene Therapy?
-
Apr 19, 2026, 15:42S. Kate Hartman: A Clinical Framework for Anemia, Bleeding, and Transfusion Decision-Making
-
Apr 19, 2026, 15:20CHAMPION-AF Demonstrated Better Freedom From Clinically Relevant Bleeding Events – Boston Scientific Cardiology
-
Apr 19, 2026, 14:37Jean-Jacques Mourad: Cohort Study Insights on Aspirin Use in Patients with Horton’s Disease
-
Apr 19, 2026, 14:36Francisco Ujueta: Pulmonary Embolism Care Doesn’t End at the Acute Phase
-
Apr 19, 2026, 14:35Flora Peyvandi: Marking the Beginning of a Future with Less Suffering on World Haemophilia Day
-
Apr 19, 2026, 14:34Chokri Ben Lamine: 50 High-Yield Pearls on Hemoglobin Cutoffs for Anaemia from WHO 2024 Guideline
-
Apr 19, 2026, 14:31Kate Iyore: Simple Explanation of Deep Vein Thrombosis and Pulmonary Embolism
-
Apr 19, 2026, 14:08Emily Smith: From Personal Experience to Global Advocacy on World Haemophilia Day